According to Agile Therapeutics 's latest financial reports the company's current EPS (TTM) is -HK$307.55. In 2022 the company made an earnings per share (EPS) of -HK$1,986 an increase over its 2021 EPS that were of -HK$12,128.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$310.33 | -84.38% |
2022 | -HK$1,986 | -83.62% |
2021 | -HK$12,128 | 30% |
2020 | -HK$9,329 | 53.85% |
2019 | -HK$6,064 | -32.76% |
2018 | -HK$9,018 | -36.26% |
2017 | -HK$14,149 | -9.9% |
2016 | -HK$15,704 | -26.28% |
2015 | -HK$21,302 | 21.79% |
2014 | -HK$17,490 | -29.13% |
2013 | -HK$24,680 |